A Study of Lower Dose Radiation Therapy for People With Prostate Cancer
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexMale
Age18+
SponsorMemorial Sloan Kettering Cancer Center
About this trial
The purpose of this study is to see whether giving a lower (de-escalated) dose of radiation therapy to some parts of the prostate can reduce side effects compared to giving the same (uniform) dose of radiation therapy to the whole prostate.
Eligibility criteria
Qualifiers
Documentation of Disease
Definition of Disease
Grade Group (GG) 1, 2, or 3.
PSA less than 20 ng/mL prior to starting ADT, if used.
Disqualifiers
None
Trial design
Treatments tested in this trial
- MR-guided Stereotactic Body Radiation Therapy
Treatment groups
54 Participants
are divided into 2 treatment groupsLocations
7Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)07920, Basking RidgeNew Jersey, United States
Memorial Sloan Kettering at Monmouth (Limited Protocol Activities)07748, MiddletownNew Jersey, United States
Memorial Sloan Kettering at Bergen (Limited Protocol Activities)07645, MontvaleNew Jersey, United States
Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities)11725, CommackNew York, United States
Sponsors and collaborators
Memorial Sloan Kettering Cancer Center
Lead sponsor
Source ClinicalTrials.gov